tbkg.osimertinib_case_study

is a Product.

Clinical validation dataset with calculated ADRs for osimertinib ranked by importance, biomarker pathways explaining drug-ADR relationships, and clinical data from 8 lung adenocarcinoma patients. Model achieved Kappa=0.68 concordance with official manual and 0.81 three-fold cross-validation accuracy.

Format

mixed

License

Warning: No license entered

External IDs

No external IDs available

Latest Version

Unknown

Sources

Original Source(s)
Secondary Source(s)
ID Relation
umls was influenced by

Is this information incorrect or incomplete? Request an update.